Gene Therapies for the Treatment of Leber Hereditary Optic Neuropathy

19Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Leber hereditary optic neuropathy (LHON) is a rare, blinding, maternally inherited mitochondrial genetic disease in need of effective treatment. LHON is a nonsyndromic optic neuropathy affecting the retinal ganglion cells (RGCs), whose axons form the optic nerve and extend into the brain via the optic chiasm and optic tracts. The physiopathology of LHON is characterized by selective loss of RGCs and their axons, which leads to rapidly progressive bilateral central vision loss.

Cite

CITATION STYLE

APA

Sahel, J. A., Newman, N. J., Yu-Wai-Man, P., Vignal-Clermont, C., Carelli, V., Biousse, V., … Taiel, M. (2021). Gene Therapies for the Treatment of Leber Hereditary Optic Neuropathy. International Ophthalmology Clinics, 61(4), 195–208. https://doi.org/10.1097/IIO.0000000000000364

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free